NEWS | Mar 30, 2021
The fact that we can differentiate between all three stroke subtypes makes us stronger than our competition,” Sense Neuro Diagnostics CEO Geoff Klass recently told reporter Liz Engel of CincyInno. “We feel very comfortable with our position. When it comes to in-hospital monitoring, we’re the only company developing a product to handle that.”
The interview was published after Sense took the crown in CincyInno’s 2021 Tech Madness startup bracket challenge. You can read the full story here.